Botox

Botox Maker Allergan Sold to AbbVie for $63B
M&A

Botox Maker Allergan Sold to AbbVie for $63B

AbbVie faces pressure to diversify its portfolio as Humira, the world’s best-selling drug, faces increased competition from cheaper versions in Europe.
By Lauren Muskett | June 25, 2019
Read More
Allergan Buys CoolSculpting Company for $2.4B
Strategy

Allergan Buys CoolSculpting Company for $2.4B

The acquisition of Zeltiq Aesthetics' system for using cooling to eliminate fat cells gives Allergan access to the growing body-contouring market.
By Matthew Heller | February 13, 2017
Read More